198480-07-8

Basic information

• Product Name: 5-benzyloxy-2-(4-benzyloxy-phenyl)-1-[4-(2-bromo-ethoxy)-benzyl]-3-methyl-1H-indole
• Synonyms: 5-benzyloxy-2-(4-benzyloxy-phenyl)-1-[4-(2-bromo-ethoxy)-benzyl]-3-methyl-1H-indole
• CAS NO: 198480-07-8
• Molecular Weight: 632.597
• Mol File: 198480-07-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 5-benzyloxy-2-(4-benzyloxy-phenyl)-1-[4-(2-bromo-ethoxy)-benzyl]-3-methyl-1H-indole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-benzyloxy-2-(4-benzyloxy-phenyl)-1-[4-(2-bromo-ethoxy)-benzyl]-3-methyl-1H-indole(198480-07-8)
• EPA Substance Registry System: 5-benzyloxy-2-(4-benzyloxy-phenyl)-1-[4-(2-bromo-ethoxy)-benzyl]-3-methyl-1H-indole(198480-07-8)

Safety Data

• Hazardous Substances Data: 198480-07-8(Hazardous Substances Data)

Upstream product

• 70-70-2 4-hydroxypropiophenone 
• 100-39-0 benzyl bromide 
• 4495-66-3 4-benzyloxypropiophenone 
• 103258-64-6 ethyl 2-(4-hydroxymethylphenoxy)acetate 
• 80494-75-3 ethyl [p-(chloromethyl)phenoxy]acetate 
• 51388-20-6 4-benzyloxyaniline hydrochloride 
• 198479-95-7 2-(4-((5-(benzyloxy)-2-(4-(benzyloxy)phenyl)-3-methyl-1H-indol-1-yl)methyl)phenoxy)ethanol 
• 198479-82-2 {4-[5-benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-indol-1-ylmethyl]-phenoxy}-acetic acid ethyl ester 

Downstream Products

• 198480-21-6 5-benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-1H-indole 
• 198481-32-2 bazedoxifene 
• 198480-55-6 pipendoxifene 
• 198480-20-5 5-benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indole 

Relevant articles and documents

Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens

-

2-PHENYL-1-[-(2-AMINOETHOXY)-BENZYL -INDOLE IN COMBINATION WITH ESTROGENS

-

2-PHENYL-1-[4-(2-AMINOETHOXY)-BENZYL]-INDOLES AS ESTROGENIC AGENTS

The present invention relates to new 2-Phenyl-1-[4-(2-Aminoethoxy)-Benzyl]-Indole compounds which are useful as estrogenic agents, as well as pharmaceutical compositions and methods of treatment utilizing these compounds, which have the general structures below: STR1